Codexis Reports First Quarter 2026 Financial Results
Codexis reported first quarter 2026 revenue of $15.2 million, more than doubling the $7.5 million reported in the prior year period. The revenue increase was primarily due to the recognition of $6.3 million from the Merck Technology Transfer agreement, while product gross margin improved to 71% from 55%.
Key figures
- Revenue
- $15.2 million
- Guidance
- $72 million to $76 million
- Cash
- 65100000
- Net loss
- 8700000
- Rd expenses
- 11400000
- Gross margin
- 71%
- Sga expenses
- 9800000
AI analysis
Red flags1 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.